Dattatraya Prajapati
Medical Oncology · Owensboro, KYNPI 1912996661
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.0% of the total across 218 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 40 manufacturers, the largest accounting for just 10.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,690 and has fallen 92.6% since, to $125 in 2022. That places this record below the midpoint for medical oncology clinicians in KY, where the typical reported total is $3,396.
Across 218 payments — averaging $15.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$349
- Merck$266
- AstraZeneca$254
- Pfizer$254
- E.r. Squibb & Sons, L.L.C.$229
- Astellas Pharma US Inc$223
- plus $2K from 34 others
What the payments were for
- Food & beverage$3,22695%
- Education$1705%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 13 | $349 |
| Merck | 20 | $266 |
| AstraZeneca | 16 | $254 |
| Pfizer | 23 | $254 |
| E.r. Squibb & Sons, L.L.C. | 15 | $229 |
| Astellas Pharma US Inc | 11 | $223 |
| Johnson & Johnson | 13 | $192 |
| Novartis | 13 | $185 |
| Lilly USA, LLC | 11 | $167 |
| Seagen Inc. | 8 | $136 |
| Genentech USA, Inc. | 7 | $104 |
| Eisai Inc. | 6 | $95 |
| Clovis Oncology, Inc. | 6 | $85 |
| Boehringer Ingelheim | 4 | $69 |
| Pharmacyclics LLC, An Abbvie Company | 5 | $68 |
| Ipsen Biopharmaceuticals, Inc | 3 | $66 |
| Daiichi Sankyo Inc. | 3 | $53 |
| Sanofi | 3 | $52 |
| Bayer | 3 | $49 |
| Array Biopharma Inc | 3 | $46 |
| Gilead | 3 | $41 |
| Puma Biotechnology, Inc. | 2 | $32 |
| Teva Pharmaceuticals USA, Inc. | 2 | $31 |
| Kyowa Kirin, Inc. | 2 | $30 |
| Tesaro, Inc. | 2 | $29 |
| Beigene USA, Inc. | 2 | $29 |
| Foundation Medicine, Inc. | 2 | $29 |
| GSK | 2 | $27 |
| Dova Pharmaceuticals | 2 | $26 |
| Exelixis Inc. | 2 | $26 |
| Bristol Myers Squibb | 2 | $24 |
| Ferring Pharmaceuticals Inc. | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Rigel Pharmaceuticals, Inc. | 1 | $16 |
| AMAG Pharmaceuticals, Inc. | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Sun Pharmaceutical Industries Inc. | 1 | $13 |
| AbbVie | 1 | $13 |
| Taiho Oncology, Inc. | 1 | $12 |
| Pharmacosmos Therapeutics Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Prolia$125
How this compares
$3,396 in reported general payments places this provider in the 50th percentile of 53 medical oncology providers in Kentucky.
Other medical oncology in Owensboro
- Jewraj MaheshwariOwensboro$36K
- Minsig ChoiEdgewood$348K
- Lowell AnthonyLexington$55K
- Matthew KurianEdgewood$47K
- Emmanuel NidhiryLouisville$34K
- John HammLouisville$26K
- Wederson ClaudinoPaducah$25K
- Renato la RoccaLouisville$24K
- Kent TaylorGeorgetown$22K
- Douglas FloraEdgewood$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.